| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/16/2002 | EP1171463A2 Peptide homodimers and peptide heterodimers, derived from interferon alpha 2 |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171460A1 48 human secreted proteins |
| 01/16/2002 | EP1171459A1 Angiopoietin-like proteins, crisp proteins and polynucleotides encoding same |
| 01/16/2002 | EP1171458A1 50 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171456A1 50 human secreted proteins |
| 01/16/2002 | EP1171455A1 Polypeptide-k obtained from momordica charantia and a process for the extraction thereof |
| 01/16/2002 | EP1171452A2 Pyrrolidincarbolylamino cyclic disulfides as vcam-vla4 antagonists |
| 01/16/2002 | EP1171451A1 Separation of plasma components |
| 01/16/2002 | EP1171166A1 Benzodiazepine derivatives for imaging thrombi |
| 01/16/2002 | EP1171165A1 Intramyocardial injection of autologous bone marrow |
| 01/16/2002 | EP1171163A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders |
| 01/16/2002 | EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 01/16/2002 | EP1171156A1 Novel use within transplantation surgery |
| 01/16/2002 | EP1171155A2 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/16/2002 | EP1171154A2 Uses of mammalian ox2 protein and related reagents |
| 01/16/2002 | EP1171153A2 Novel medical use of alpha-1-acidic glycoprotein (aag) or orosomucoid |
| 01/16/2002 | EP1171152A1 vMIP-II PEPTIDE ANTAGONISTS OF CXCR4 |
| 01/16/2002 | EP1171151A1 Thrombospondin-2 and uses thereof |
| 01/16/2002 | EP1171150A2 Pseudomycin antifungal compositions and methods for their use |
| 01/16/2002 | EP1171149A1 Inhibition of proteasome function induces programmed cell death in endothelial cells |
| 01/16/2002 | EP1171148A2 Soluble tumor necrosis factor receptor treatment of medical desorders |
| 01/16/2002 | EP1171147A1 Modulation of excitable tissue function by peripherally administered erythropoietin |
| 01/16/2002 | EP1171143A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 01/16/2002 | EP1171131A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 01/16/2002 | EP1171129A1 Use of glucosylceramide synthesis inhibitors in therapy |
| 01/16/2002 | EP1171125A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171119A1 Methods of treating clinical diseases with isoflavones |
| 01/16/2002 | EP1171115A1 Methods of delivery of cetyl myristoleate |
| 01/16/2002 | EP1171109A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
| 01/16/2002 | EP1171098A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes |
| 01/16/2002 | EP1171093A2 Skin care compositions containing combination of skin care actives |
| 01/16/2002 | EP1171090A2 Methods for regulating the condition of mammalian keratinous tissue |
| 01/16/2002 | EP1171089A2 Skin care compositions containing combination of skin care actives |
| 01/16/2002 | EP1171081A2 Skin care compositions containing combination of skin care actives |
| 01/16/2002 | EP1171078A2 Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol |
| 01/16/2002 | EP1170993A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
| 01/16/2002 | EP1170992A1 PURIFIED AND ISOLATED $i(piwi) FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME |
| 01/16/2002 | EP0932617B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/16/2002 | EP0896585B1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 01/16/2002 | EP0871732A4 Method of treating sepsis |
| 01/16/2002 | EP0866701B1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound |
| 01/16/2002 | EP0859626B1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation |
| 01/16/2002 | EP0817859B1 Recombinant dna vectors for gene therapy |
| 01/16/2002 | EP0817645B1 Use of gonadotropin in the treatment of benign prostatic hypertrophy |
| 01/16/2002 | EP0811071B1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 01/16/2002 | EP0791358B1 Therapeutic agent for ophthalmic diseases |
| 01/16/2002 | EP0722344B1 Process for virus deactivation in the presence of a polyether and an agens |
| 01/16/2002 | EP0721467B1 Use of relaxin as an analgesic and palliative for intractable pain |
| 01/16/2002 | EP0697875B1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/16/2002 | EP0672681B1 Novel antitumor peptide |
| 01/16/2002 | EP0672180B1 Oligonucleotide modulation of protein kinase c |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331602A Methods of downmodulating immune response to therapeutic proteins |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331565A Method for producing granulates contg. enzymes |
| 01/16/2002 | CN1331558A Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/16/2002 | CN1331340A Polypeptide-human topoisomerase 12.1 and polynucleotide for coding it |
| 01/16/2002 | CN1331339A Polypeptide-human DNA topoisomerase I 11.44 and polynucleotide for coding it |
| 01/16/2002 | CN1331338A Polypeptide-dihydroorotase 12 and polynucleotide for coding it |
| 01/16/2002 | CN1331337A Polypeptide-human ATP dependent serine protein hydrolase 12 and polynucleotide for coding it |
| 01/16/2002 | CN1331336A Polypeptide-human protein tyrosine phosphatase 9.57 and polynucleotide for coding it |
| 01/16/2002 | CN1331335A Polypeptide-human glycosyl hydrolase 15 and polynucleotide for coding it |
| 01/16/2002 | CN1331334A Polypeptide-RNA uncoiling enzyme A21.01 and polynucleotide for coding it |
| 01/16/2002 | CN1331333A Polypeptide-Na/K adenosine triphosphatase beta-2 subunit (atpb2) 15.07 and polynucleotide for coding it |
| 01/16/2002 | CN1331332A Polypeptide-human dihydropyrimidinase associated protein-1 (DRP-1) 9.35 and polynucleotide for coding it |
| 01/16/2002 | CN1331331A Polypeptide-human RNA uncoiling enzyme 12 and polynucleotide for coding it |
| 01/16/2002 | CN1331330A Polypeptide-human protein phosphatase 12.43 and polynucleotide for coding it |
| 01/16/2002 | CN1331328A Polypeptide-Na/K adenosine triphosphatase beta-2 subunit (atpb2) 9.57 and polynucleotide for coding it |
| 01/16/2002 | CN1331327A Polypeptide-human striatum-enriched phosphatase 14.85 and polynucleotide for coding it |
| 01/16/2002 | CN1331326A Polypeptide-human arginine methyltransferase (HRMT) 32.12 and polynucleotide for coding it |
| 01/16/2002 | CN1331325A Polypeptide-human serine/threonine protein kinase 15.18 and polynucleotide for coding it |
| 01/16/2002 | CN1331324A Polypeptide-periodic protein dependent kinase-CDK 411 and polynucleotide for coding it |
| 01/16/2002 | CN1331322A Polypeptide-human leucine zipper contained kinase 12.65 and polynucleotide for coding it |
| 01/16/2002 | CN1331320A Polypeptide-human hydroxyindole-0-methyltransferase 12.43 and polynucleotide for coding it |
| 01/16/2002 | CN1331319A Polypeptide-SR protein-specific serine kinase 212.98 and polynucleotide for coding it |
| 01/16/2002 | CN1331318A Polypeptide-3-phosphoinositide dependent protein kinase D1(PKDT) 45.32 and polynucleotide for coding it |
| 01/16/2002 | CN1331317A Polypeptide-human serine/threonine protein kinase 11.22 and polynucleotide for coding it |
| 01/16/2002 | CN1331315A Polypeptide-human phosphorylcholine/ethano/amine transferase 15.29 and polynucleotide for coding it |
| 01/16/2002 | CN1331314A Polypeptide-human serine/threonine protein kinase 9.13 and polynucleotide for coding it |
| 01/16/2002 | CN1331313A Polypeptide-human p70 ribosome S6 kinase 11.77 and polynucleotide for coding it |
| 01/16/2002 | CN1331312A Polypeptide-human receptor-independent tyrosine kinase 9.24 and polynucleotide for coding it |
| 01/16/2002 | CN1331311A Polypeptide-human sulfotransferase 11.44 and polynucleotide for coding it |
| 01/16/2002 | CN1331310A Polypeptide-human serine/threonine protein kinase 10.67 and polynucleotide for coding it |
| 01/16/2002 | CN1331308A Polypeptide-human I kappa B kinase 15 and polynucleotide for coding it |
| 01/16/2002 | CN1331307A Polypeptide-human P70 ribosome S6 kinase 13.97 and polynucleotide for coding it |
| 01/16/2002 | CN1331306A Polypeptide-human GDP-L-fucose pyrophosphorylase 12.98 and polynucleotide for coding it |
| 01/16/2002 | CN1331305A Polypeptide-human glutaryl-Coa dehydrogenase 15.51 and polynucleotide for coding it |
| 01/16/2002 | CN1331304A Polypeptide-human glutaryl-CoA dehydrogenase 16.17 and polynucleotide for coding it |
| 01/16/2002 | CN1331303A Polypeptide-pterin Mo oxide-reductase 9 and polynucleotide for coding it |
| 01/16/2002 | CN1331300A Polypeptide-RNA polymerase II subunit 11 and polynucleotide for coding it |
| 01/16/2002 | CN1331298A Polypeptide-human DNA-dependent RNA polymerase AC40 subunit inhibitor 9.68 and polynucleotide for coding it |
| 01/16/2002 | CN1331296A Polypeptide-deoxycytidinephosphate deaminase 10.12 and polynucleotide for coding it |
| 01/16/2002 | CN1331295A Polypeptide-human DNA polymerase delta 12.65 and polynucleotide for coding it |
| 01/16/2002 | CN1331294A Polypeptide-RNA3' terminal phosphate cyclase 9.24 and polynucleotide for coding it |
| 01/16/2002 | CN1331293A Polypeptide-histidine tRNA synthetase 11.99 and polynucleotide for coding it |
| 01/16/2002 | CN1331292A Polypeptide-human beta-1,4 galactosyltransferase 13.2 and polynucleotide for coding it |
| 01/16/2002 | CN1331291A Polypeptide-citrate synthetase 12.21 and polynucleotide for coding it |